These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2834657)

  • 1. Serum angiotensin-converting enzyme is not an indicator of dialyzer membrane biocompatibility.
    Docci D; Turci F; Baldrati L; Delvecchio C
    Nephron; 1988; 48(4):335. PubMed ID: 2834657
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of different dialyzer membranes on serum angiotensin-converting enzyme during hemodialysis.
    Docci D; Delvecchio C; Turci F; Baldrati L; Gollini C
    Int J Artif Organs; 1988 Jan; 11(1):28-32. PubMed ID: 2834297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum angiotensin-converting enzyme during haemodialysis: effect of membrane biocompatibility.
    Maher ER; Bird R; Kyle P; Curtis JR
    Nephron; 1987; 45(4):328. PubMed ID: 3035394
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum angiotensin-converting enzyme as a marker of dialyzer membrane biocompatibility?
    Krämer BK; Ulshöfer T; Ress KM; Müller GA; Risler T
    Nephron; 1989; 53(2):162-3. PubMed ID: 2554165
    [No Abstract]   [Full Text] [Related]  

  • 5. Biocompatibility of a polycarbonate membrane. A preliminary report.
    De Broe ME; van Waeleghem JP; Heyrman R; De Backer W
    Blood Purif; 1986; 4(1-3):168-71. PubMed ID: 3015165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum angiotensin-converting enzyme increases during hemodialysis. Evidence for injury of the pulmonary vascular endothelium?
    Nielsen AH; Knudsen F; Kristensen SD
    Nephron; 1985; 40(1):100-3. PubMed ID: 2987714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis.
    Vanholder RC; Ringoir SM
    Blood Purif; 1990; 8(1):32-44. PubMed ID: 2198890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence of blood cells to dialyzer membranes as a measure of biocompatibility.
    Kjellstrand P; Okmark P; Odselius R; Thysell H; Riede G; Holmquist B
    Int J Artif Organs; 1991 Nov; 14(11):698-702. PubMed ID: 1757156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of dialyzer biocompatibility in acute renal failure.
    Vanholder R; De Vriese A; Lameire N
    Blood Purif; 2000; 18(1):1-12. PubMed ID: 10686437
    [No Abstract]   [Full Text] [Related]  

  • 10. [The influence of dialysis dose and the dialyzer membrane biocompatibility on the outcome of acute renal failure].
    Kes P; Sefer S
    Lijec Vjesn; 1999; 121(9-10):326-8. PubMed ID: 19662688
    [No Abstract]   [Full Text] [Related]  

  • 11. Biocompatibility of dialysis membrane.
    Kes P
    Acta Med Croatica; 1999; 53(1):29-40. PubMed ID: 10437275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of dialyzer geometry on blood coagulation and biocompatibility.
    Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
    Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatibility differences with respect to the dialyzer sterilization method.
    Müller TF; Seitz M; Eckle I; Lange H; Kolb G
    Nephron; 1998; 78(2):139-42. PubMed ID: 9496728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatibility aspects of chronic hemodialysis and their clinical relevance.
    Wauters JP
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S19-23. PubMed ID: 8608656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein adsorption on dialyzer membranes influences their biocompatibility properties.
    Kuwahara T; Markert M; Wauters JP
    Contrib Nephrol; 1989; 74():52-7. PubMed ID: 2562019
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of dialyzer membranes on in vitro generation of eicosanoids.
    Schultze G; Wagner K; Neumayer HH; Fitzner R; Molzahn M
    Int J Artif Organs; 1987 Jul; 10(4):275-8. PubMed ID: 3478308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical testing of a new, low-flux polysulfone membrane. Results of a 26-week study.
    Honkanen E; Grönhagen-Riska C; Teppo AM; Hiltunen U
    Blood Purif; 1989; 7(5):240-6. PubMed ID: 2679793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical consequences of blood flow-dialyzer membrane interactions in acute renal failure.
    Schiffl H; Küchle C; Lang SM
    Blood Purif; 1997; 15(4-6):366-81. PubMed ID: 9435965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.